Novartis AG – Company Profile and SWOT Analysis

Novartis AG – Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Novartis AG (Novartis) is engaged in research, development, manufacturing, distribution, marketing, and sale of innovative medicines. It provides a diverse range of products across various therapeutic areas, including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis distributes its products to a wide array of stakeholders, including pharmacists, private health systems, government agencies, physicians, hospitals, insurance groups, managed care providers, pharmacy benefit managers, and government-supported healthcare systems, under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, on a global scale. It operates manufacturing facilities in the US, Switzerland, Austria, Slovenia, China, France, and Italy. Novartis is headquartered in Basel, Switzerland.

Scope

– Detailed information on Novartis AG required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis

– An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments

– Intelligence on Novartis AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Novartis AG, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Novartis AG and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Novartis AG as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Novartis AG's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Novartis AG: Company Overview

Novartis AG: Overview and Key Facts

Novartis AG: Overview

Novartis AG: Key Facts

Novartis AG: Key Employees

Novartis AG: Key Employee Biographies

Novartis AG: Major Products and Services

Novartis AG: Management Statement

Novartis AG: Locations and Subsidiaries

Novartis AG: Key Competitors

Novartis AG: Company Analysis

Novartis AG: Business Description

Novartis AG: SWOT Analysis

Novartis AG: SWOT Overview

Novartis AG: Strengths

Novartis AG: Weaknesses

Novartis AG: Opportunities

Novartis AG: Threats

Novartis AG: Corporate Financial Deals Activity

Novartis AG: Financial Deals Overview

Novartis AG: Targets and Partners

Novartis AG: Top Deals 2021 - 2025YTD*

Novartis AG: Advisors

Novartis AG: Top Legal Advisors

Novartis AG: Top Financial Advisors

Novartis AG: Mergers and Acquisitions

Novartis AG: Corporate Venturing

Novartis AG: Partnership

Novartis AG: Divestments

Novartis AG: Recent Developments

Novartis AG: News and Events Summary

Novartis AG: Business Expansion

Novartis AG: Corporate Governance

Novartis AG: Financial Performance

Novartis AG: Market Developments

Novartis AG: Research & Development

Novartis AG: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Novartis AG: Key Facts

Table 2: Novartis AG: Key Employees

Table 3: Novartis AG: Locations and Subsidiaries

Table 4: Novartis AG: Key Competitors

Table 5: Novartis AG: Deal Activity by Deal Type – Volume (TTM*)

Table 6: Novartis AG: M&A Activity by Geography (TTM*)

Table 7: Novartis AG: Deal Activity by Deal Type – Volume (2021 – YTD*2025)

Table 8: Novartis AG: M&A Average Deal Size – Value (US$m)

Table 9: Novartis AG: Targets and Partners

Table 10: Novartis AG: Top Deals 2021 – 2025YTD*

Table 11: Novartis AG: Legal Advisor Ranking by Value (US$m)

Table 12: Novartis AG: Financial Advisor Ranking by Value (US$m)

Table 13: Novartis AG: M&A Volume and Value Trend (2021 – YTD*2025)

Table 14: Novartis AG: M&A Activity by Geography (2021 – YTD*2025)

Table 15: Novartis AG: Corporate Venturing Volume and Value Trend (2021 – YTD*2025)

Table 16: Novartis AG: Corporate Venturing by Geography (2021 – YTD*2025)

Table 17: Novartis AG: Partnership Volume and Value Trend (2021 – YTD*2025)

Table 18: Novartis AG: Partnership Trend by Deal Type (2021 – YTD*2025)

Table 19: Novartis AG: Divestments Volume and Value Trend (2021 – YTD*2025)

Table 20: Novartis AG: Divestments by Geography (2021 – YTD*2025)

Table 21: Novartis AG: News and Events Summary

Table 22: Novartis AG: Business Expansion

Table 23: Novartis AG: Corporate Governance

Table 24: Novartis AG: Financial Performance

Table 25: Novartis AG: Market Developments

Table 26: Novartis AG: Research & Development

Table 27: Novartis AG: Strategy and Operations

List of Figures

List of Figures

Figure 1: Novartis AG: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Novartis AG: M&A Activity by Geography (TTM*)

Figure 3: Novartis AG: Deal Activity by Deal Type – Volume (2021 – YTD*2025)

Figure 4: Novartis AG: M&A Average Deal Size – Value (US$m)

Figure 5: Novartis AG: M&A Volume and Value Trend (2021 – YTD*2025)

Figure 6: Novartis AG: M&A Activity by Geography (2021 – YTD*2025)

Figure 7: Novartis AG: Corporate Venturing Volume and Value Trend (2021 – YTD*2025)

Figure 8: Novartis AG: Corporate Venturing by Geography (2021 – YTD*2025)

Figure 9: Novartis AG: Partnership Volume and Value Trend (2021 – YTD*2025)

Figure 10: Novartis AG: Partnership Trend by Deal Type (2021 – YTD*2025)

Figure 11: Novartis AG: Divestments Volume and Value Trend (2021 – YTD*2025)

Figure 12: Novartis AG: Divestments by Geography (2021 – YTD*2025)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports